期刊文献+

乳腺癌易感基因BRCA1的BRCT结构域的融合表达及纯化 被引量:1

Purification of BRCT domain of BRCA1 and expression in E.coli DH5α
下载PDF
导出
摘要 乳腺癌易感基因BRCA1在乳腺癌发生、发展中起着重要作用。在其C 末段有两个串联重复的BRCT(BRCT1和BRCT2 )结构域。它们与BRCA1的重要功能密切相关 ,BRCT结构域还存在于其它 5 0多种蛋白中。本文用PCR方法扩增了BRCT1和BRCT2结构域编码序列 ,并将其以正确相位与pGEX 2T载体中的GST编码序列融合 ,构建成重组质粒pGST BRCT1和pGST BRCT2。将这两种重组质粒分别转化E coliDH5α后 ,分别表达了GST BRCT1和GST BRCT2两种融合蛋白。Westernblot检测结果表明 ,两种融合蛋白均能与GST抗体反应。表达的GST BRCT1和GST BRCT2经GST Sepharose 4B亲和层析获得了纯化的融合蛋白 。 Breast cancer susceptibility gene (BRCA1) plays an important role in the development and progression of breast cancer. There are two repeats of BRCA1 C Teminal domain at its C temimus(BRCT1 and BRCT2) that are required for its function in both transcriptional activation and DNA repairing. BRCT domains have been identified in more than 50 other proteins. In this study, the coding sequences of BRCT1 and BRCT2 domains were amplified by PCR and fused into frame with the coding region of GST in the pGEX 2T vector to generate the pGST BRCT1 and pGST BRCT2 recombinant plasmids. In the optimal conditions, the fusion proteins GST BRCT1 and GST BRCT2 were expressed in E.coli DH5α at higher level. The western blot analysis showed that GST BRCT1 and GST BRCT2 interacted with GST antibody. The fusion proteins were purified by GST Sepharose 4B affinity chromatography.
出处 《基础医学与临床》 CSCD 北大核心 2003年第2期141-145,共5页 Basic and Clinical Medicine
关键词 乳腺癌 易感基因 BRCAL BRCT 结构域 融合表达 纯化 BRCA BRCT fusion expression purification
  • 相关文献

参考文献9

  • 1Easton DF, Bishop DT, Ford D, et al. Breast cancer linkage consortium[J] .Ibid, 1993, 52: 678.
  • 2Miki Y, Swensen J, Shatluck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 [J]. Science, 1994,266 : 66 - 67.
  • 3Cortez D, wang Y, Qin J, et al. Requirement of ATM-depondent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks [ J ]. Science, 1999,286 : 1162 - 1166.
  • 4Scully R, Ganesan S, Vlasakova K, et al. Genetic analysis of BRCA1 function in a defined tumor cell line [J]. Mol Cell.1999,4:1093 - 1099.
  • 5Ye Qinong, Hu YF, Zhong HG, et al. BRCAl-induced largescale chromatin unfolding and allele-specific effects of cancerpredisposing mutations[J]. J of Cell Biology, 2001,155:911-921.
  • 6Bork P, Hofmann K, Butcher AF, et al. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins[J] .FASEB J, 1997, 11:68 - 76.
  • 7Nash RA, Caldecoff KW, Barnes DE, et al. XRCC1 protein interacts with one of the two distinct forms of DNA ligase Ⅲ [ J ].Biochemistry, 1997, 36: 5207- 5211.
  • 8Ouchi T, Monteiro ANA, August A, et al. BRCA1 regulates p53 -dependent gene expression[J]. Proc Natl Acad Sci USA,1998, 95 : 2302 - 2306.
  • 9Yamane K, Tsuruo T. Conserved BRCT regions of TopBP1 and of the tumor suppressor BRCA1 bind strand breaks and terminic of DNA[J]. Oncogene, 1999, 18: 5194-5203.

同被引文献26

  • 1Okada S, Ouchi T. Cell cycle differences in DNA damage-induced BRCA1 phosphorylation affect its subcellular localization. J Biol Chem,2003,278(3) :2015 ~ 2020.
  • 2Xu X,Weaver Z,Linke S P, Li C, Gotay J, Wang X W, Harris C C, Ried T, Deng C X. Conditional mutation of Brcal in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet, 1999,22(1) :37 - 43.
  • 3Xu X, Qiao W, Linke S P, Cao L, Li W M, Furth P A, Harris C C, Deng C X. Genetic interactions between tumor suppressors Brcal and p53 in apoptosis, cell cycle and tumorigenesis. Nat Genet, 2001,28 (3) :266 ~ 271.
  • 4YE Q, Hu Y F,Zhong H, Li R, Nye A C, Belmont A S, Li R. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J Cell Biol, 2001, 155 (6) : 911-921.
  • 5Genini M, Schwalbe P, Scholl F A, Remppis A, Mattei M G, Schafer BW. Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. DNA Cell Biol, 1997,16(4) :422 - 433.
  • 6Zhang H, Somasundaram K, Peng Y, Tian H, Zhang H, Bi D, Weber B L. BRCAI physically associates with p53 and stimulates its transcriptional activity. Oncogene, 1998,16(13) : 1713 - 1721.
  • 7Muller J M, Isele U, Metzger E, Rempel A, Moser M, Pscherer A,Breyer T, Holubarsch C, Buettner R, Schule R. FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO, 2000, 19 (3):359 ~ 369.
  • 8Pao G M, Janknecht R, Ruffner H, Hunter T, Verma I M. CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc Natl Acad Sci USA ,2000,97(3):1020 ~ 1025.
  • 9Fimia G M, de Cesare D, Sassone-Corsi P. A family of LIM-only transcriptional coaetivators: tissue-specific expression and selective actiration of CREB and CREM. Mol Cell Biol, 2000,20(22) : 8613 ~8622.
  • 10Li S, Chen P L, Subramanian T, Chinnadurai G, Tomlinson G, Osborne C K, Sharp Z D, Lee W H. Binding of CtIP to the BRCT repeats of BRCAI involved in the transcription regulation of p21 is disrupted upon DNA damage. J Biol Chem. 1999,274(16) : 11334 - 11335.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部